FDA NDC Directory · JSON-LD · Markdown

Docusate Sodium and Sennosides

NDC 87717-502 · HUMAN OTC DRUG · TABLET

Labeler / ManufacturerMorepen Bio Inc
Marketing categoryOTC monograph drug · App M007
Dosage form / routeTABLET · ORAL
Active ingredientsDOCUSATE SODIUM (50 mg/1)
SENNOSIDES (8.6 mg/1)
Marketing started20260710
Package count2

External sources

Source: openFDA. Public-domain (CC0).